Page last updated: 2024-10-25

deferoxamine and Coagulation Disorders, Blood

deferoxamine has been researched along with Coagulation Disorders, Blood in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schettini, F1
De Mattia, D1
Arcamone, G1
Sabato, V1
Altomare, M1
Burattini, MG1
Fedele, F1
Compagnone, A1
Ciavarella, G1
Tenenbein, M1
Israels, SJ1

Other Studies

2 other studies available for deferoxamine and Coagulation Disorders, Blood

ArticleYear
Coagulation contact phase factors and inhibitors in beta-thalassemia major children.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:3

    Topics: Adolescent; Blood Coagulation Disorders; Child; Combined Modality Therapy; Deferoxamine; Humans; Pla

1987
Early coagulopathy in severe iron poisoning.
    The Journal of pediatrics, 1988, Volume: 113, Issue:4

    Topics: Adolescent; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Child, Preschool; D

1988